Trey Thoelcke - Editor for 24/7 Wall St.
Lastest Stories by Trey Thoelcke
As of the most recently reported period, short sellers still favored Microsoft, Intel and Pfizer above all other Dow stocks.
Published:
Last Updated:
As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.
Published:
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
Published:
Last Updated:
Here are five stocks of popular consumer services providers that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Published:
24/7 Wall St. has put together a preview of Adobe, FedEx and some of the other most prominent earnings reports expected this week.
Published:
These are five picks for aggressive accounts looking to get share count leverage on companies with sizable upside potential.
Published:
As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.
Published:
Last Updated:
These five stocks trading under the $10 level have big upside to the analysts' price targets and they are covered with Buy ratings at major Wall Street firms.
Published:
Here are five stocks of popular services providers that recently saw their 50-day moving average cross below the 200-day average, a death cross.
Published:
Exchange traded funds are often seen as a way to diversify and to moderate the risks of investing directly into stocks during times of uncertainty. Yet, a quick look at some of the most popular...
Published:
As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.
Published:
Last Updated:
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
Published:
Here are five more stocks for aggressive accounts looking to get share count leverage on companies with sizable upside potential.
Published:
As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.
Published:
As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.